HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

PF-06454589

HCID 72706837
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1527473-30-8
Standard SMILES
Cn1cc(-c2c[nH]c3ncnc(N4CCOCC4)c23)cn1
InChIKey
VNWKCLDQBNSJJO-UHFFFAOYSA-N
Molecular formula
C14H16N6O
Average molar mass
284.32 g/mol
Monoisotopic mass
284.13855916

Names & identifiers

Preferred name
PF-06454589
IUPAC
4-[5-(1-methylpyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine
English name
5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine
Molecular formula
C14H16N6O
Molecular weight
284.32

Names & synonyms

PF-064545894-[5-(1-methylpyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholinecompound 28 [PMID: 25353650]compound 28 (PMID: 25353650)4-(5-(1-methylpyrazol-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)morpholineRefChem:1722551527473-30-8CHEMBL33934395-(1-methyl-1H-pyrazol-4-yl)-4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidineGTPL8295orb1299557SCHEMBL15401053
Show more names
CS-2879PF-06454589, 10 mM in DMSOPF 06454589PF064545895-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine4-[5-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine7H-Pyrrolo[2,3-d]pyrimidine, 5-(1-methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-Inhibitor,G2019S LRRK2,inhibit,LRRK2,parkinson's disease,PF06454589,PF 06454589,PF-06454589,Leucine-rich repeat kinase 2
SCHEMBL31123686VNWKCLDQBNSJJO-UHFFFAOYSA-NGLXC-22886EX-A2017BDBM50059307AKOS040759238NCGC00485024-01AC-35574

Database identifiers

CAS
1527473-30-8
PubChem CID
72706837
ChEMBL
CHEMBL3393439
EC Number
808-611-1

Properties

Computed structural propertiesFilling in

XLogP
0.7
Topological polar surface area
71.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
2
Heavy atoms
21
Formal charge
0
Complexity
363

Physicochemical properties

Density
1.49 · 1.49±0.1 g/cm3(Predicted)
storage temp.
room temp
solubility
10 mg/mL, · DMSO: soluble10mg/mL, clear
pka
13.16 · 13.16±0.50(Predicted)
form
powder
color
white to beige
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
264 · P264-P270-P301+P312-P330-P501
Hazard Codes
Xn
Risk Statements
22 · 22

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

risk_code
22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
Hazard statements
H302
Precautionary statements
P264-P270-P301+P312-P330-P501

Chemistry & industry

Applications

UsesPF-06447475 is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively. PF-06447475 can be used for parkinson's disease (PD) research[1].

Related reactions

2 records
New reaction record
HRID 1750262 reaction equation
HRID 1750262As product
HRID 1750290 reaction equation
HRID 1750290As reactant

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes